Cargando…
Pathological hypertrophy reverses β(2)-adrenergic receptor-induced angiogenesis in mouse heart
β-adrenergic activation and angiogenesis are pivotal for myocardial function but the link between both events remains unclear. The aim of this study was to explore the cardiac angiogenesis profile in a mouse model with cardiomyocyte-restricted overexpression of β(2)-adrenoceptors (β(2)-TG), and the...
Autores principales: | Xu, Qi, Jennings, Nicole L, Sim, Kenneth, Chang, Lisa, Gao, Xiao-Ming, Kiriazis, Helen, Lee, Ying Ying, Nguyen, My-Nhan, Woodcock, Elizabeth A, Zhang, You-Yi, El-Osta, Assam, Dart, Anthony M, Du, Xiao-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393171/ https://www.ncbi.nlm.nih.gov/pubmed/25780088 http://dx.doi.org/10.14814/phy2.12340 |
Ejemplares similares
-
Age-Related Differential Structural and Transcriptomic Responses in the Hypertensive Heart
por: Marques, Francine Z., et al.
Publicado: (2018) -
Trichostatin A accentuates doxorubicin-induced hypertrophy in cardiac myocytes
por: Karagiannis, Tom C, et al.
Publicado: (2010) -
Targeting miR-30d reverses pathological cardiac hypertrophy
por: Li, Jin, et al.
Publicado: (2022) -
Functions of Autophagy in Pathological Cardiac Hypertrophy
por: Li, Zhenhua, et al.
Publicado: (2015) -
Distinguishing transgender DNA methylation
por: El-Osta, Assam
Publicado: (2022)